세계의 안과 위탁 연구기관 시장 보고서(2025년)
Ophthalmology Contract Research Organization Global Market Report 2025
상품코드 : 1769690
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

안과 위탁 연구기관 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 이러한 성장 전망은 분산형 임상 시험 모델의 사용 확대, 안과 의료 기기 분야의 R&D 활동 증가, 정밀 의학 이니셔티브에 대한 자금 지원 확대, 소아 안과 치료 연구에 대한 관심 증가, 안과 건강 관련 신생 기업에 대한 벤처 캐피탈 투자 증가에 의해 촉진될 것으로 보입니다. 이 기간에 예상되는 새로운 동향으로는 영상 기술의 발전, AI 기반 진단 솔루션의 개발, 원격 모니터링 시스템의 사용, 3D 망막 영상 기술의 혁신, 임상 시험 관리를 위한 클라우드 기반 플랫폼의 통합 등이 있습니다.

안과 질환의 유병률이 증가함에 따라 향후 몇 년 동안 안과 위탁 연구기관 시장이 확대될 것으로 예상됩니다. 안과 질환은 눈의 구조나 기능에 영향을 미치고 시력 장애나 불편함을 유발할 수 있는 다양한 질환을 포함합니다. 이러한 질환의 증가세는 주로 고령화 인구 증가에 기인하며, 백내장, 녹내장, 황반변성, 당뇨성 망막병증 등 연령 관련 안과 질환이 점점 더 흔해지고 있습니다. 안과 위탁 연구기관은 혁신적인 안과 치료법의 개발, 테스트, 규제 승인을 가속화하는 전문 임상 연구 서비스를 제공함으로써 안과 질환 치료의 발전에 기여합니다. 예를 들어, 2023년 9월 영국 기반 전문 단체인 안과 의사 협회는 2022년 잉글랜드에서 시력 장애 신규 인증 사례가 2만 2,552건 기록되었으며, 이 중 당뇨병 관련 안과 질환 1,344건, 녹내장 3,614건, 연령 관련 황반변성 1만 865건이 포함되었다고 보고했습니다. 결과적으로, 안과 질환의 유병률이 증가하면서 안과 위탁 연구기관 시장의 성장이 가속화되고 있습니다.

안과 위탁 연구기관 시장의 선도 기업들은 임상 연구의 실행을 간소화하고 데이터 관리 능력을 개선하기 위해 통합 시험 플랫폼과 같은 혁신적인 솔루션의 개발을 우선으로 하고 있습니다. 이러한 통합 시험 플랫폼은 환자 모집, 데이터 수집, 규제 준수 등 임상 시험의 모든 측면을 관리하는 통합 디지털 시스템입니다. 이를 통해 안과 CRO는 운영 효율성을 높이고 오류를 최소화하며 새로운 안과 치료법 개발을 가속화할 수 있습니다. 예를 들어, 2024년 9월, 영국에 본사를 둔 생명공학 기업인 Lindus Health Limited는 Citrus라는 독점 통합 시험 플랫폼을 특징으로 하는 All-in-One Ophthalmology CRO를 출시했습니다. 이 플랫폼은 환자 모집, 전자 데이터 캡처(EDC), eConsent, 환자 예약 및 임상 시험 관리 시스템(CTMS) 기능과 같은 필수적인 시험 구성 요소를 맞춤형 디지털 생태계로 통합합니다. 이러한 통합을 통해 워크플로우 효율성이 향상되고 데이터 오류 가능성이 감소하며 임상 시험 프로세스 전반에 걸쳐 규제 기준을 준수할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

An ophthalmology contract research organization (CRO) is a specialized entity that assists pharmaceutical, biotechnology, and medical device companies in conducting research and clinical trials focused on eye disorders and vision-related treatments. These CROs provide either comprehensive support or targeted assistance across various stages of ophthalmic drug, biologic, or device development, ranging from preclinical evaluations to regulatory submissions and post-marketing follow-ups.

The core services offered by ophthalmology contract research organizations include early phase development, clinical research, laboratory services, and regulatory consulting. Early phase development in the ophthalmology sector involves foundational testing and research to determine the safety, dosage, and initial efficacy of novel drugs and devices prior to large-scale clinical trials. The therapeutic approaches used encompass conventional treatments, anti-inflammatory strategies (such as corticosteroids, non-steroidal anti-inflammatory drugs, and other related agents), antioxidant therapies, and cutting-edge interventions. These services are designed for diverse end-users, including pharmaceutical and biopharmaceutical firms, medical device manufacturers, and academic research institutions.

The ophthalmology contract research organization market research report is one of a series of new reports from The Business Research Company that provides ophthalmology contract research organization market statistics, including ophthalmology contract research organization industry global market size, regional shares, competitors with an ophthalmology contract research organization market share, detailed ophthalmology contract research organization market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmology contract research organization industry. The ophthalmology contract research organization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ophthalmology contract research organization market size has grown strongly in recent years. It will grow from $2.73 billion in 2024 to $2.97 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. This historical growth has been fueled by factors such as a higher prevalence of vision-related diseases, an aging global population, expanded ophthalmic drug development activities, increased globalization of clinical research, and the rising impact of chronic illnesses like diabetes.

The ophthalmology contract research organization market size is expected to see rapid growth in the next few years. It will grow to $4.07 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. This projected growth is driven by expanding use of decentralized clinical trial models, increased R&D activity in ophthalmic medical devices, greater funding in precision medicine initiatives, heightened interest in pediatric eye care research, and rising venture capital investments in eye health startups. Emerging trends anticipated in this period include progress in imaging technologies, development of AI-powered diagnostic solutions, use of remote monitoring systems, innovations in 3D retinal imaging, and integration of cloud-based platforms for trial management.

The growing prevalence of eye disorders is anticipated to drive the expansion of the ophthalmology contract research organization market in the coming years. Eye disorders encompass a broad spectrum of conditions that impact the structure or functionality of the eye, potentially leading to vision impairment or discomfort. The rise in these conditions is primarily attributed to an aging population, as age-related eye diseases such as cataracts, glaucoma, macular degeneration, and diabetic retinopathy become increasingly common. Ophthalmology contract research organizations contribute to the advancement of eye disorder treatments by offering specialized clinical research services that accelerate the development, testing, and regulatory approval of innovative ophthalmic therapies. For example, in September 2023, the Association of Optometrists, a UK-based professional body, reported that England documented 22,552 new certifications for vision impairment in 2022, including 1,344 cases linked to diabetic eye disease, 3,614 to glaucoma, and 10,865 to age-related macular degeneration. Consequently, the increasing prevalence of eye disorders is fueling the growth of the ophthalmology contract research organization market.

Leading companies in the ophthalmology contract research organization market are prioritizing the development of innovative solutions, such as integrated trial platforms, to streamline the execution of clinical studies and improve data management capabilities. These integrated trial platforms are unified digital systems that manage every aspect of clinical trials, including patient recruitment, data collection, and regulatory compliance. They allow ophthalmology CROs to enhance operational efficiency, minimize errors, and expedite the development of new ophthalmic treatments. For instance, in September 2024, Lindus Health Limited, a biotechnology firm based in the UK, introduced its All-in-One Ophthalmology CRO, featuring a proprietary integrated trial platform called Citrus. This platform consolidates essential trial components-such as patient recruitment, electronic data capture (EDC), eConsent, patient scheduling, and clinical trial management system (CTMS) functions-into a customizable digital ecosystem. This integration enhances workflow efficiency, reduces the likelihood of data errors, and ensures adherence to regulatory standards throughout the clinical trial process.

In January 2024, Iuvo Bioscience LLC, a US-based contract research organization with a focus on ophthalmology, acquired Promedica International for an undisclosed amount. This acquisition is aimed at expanding Iuvo BioScience's ophthalmic clinical CRO services by incorporating Promedica International's specialized capabilities, resulting in a comprehensive platform that supports ophthalmic research from preclinical through all clinical development phases. Promedica International is a US-based CRO that provides clinical research services to the medical device, biotechnology, and pharmaceutical industries, with a strong emphasis on ophthalmology.

Major players in the ophthalmology contract research organization market are IQVIA Holdings Inc., Eurofins Scientific SE, Syneos Health Inc., Charles River Laboratories International Inc., Parexel International Corporation, Fortrea Holdings Inc., Medpace Holdings Inc., PSI CRO AG, Worldwide Clinical Trials, The Emmes Company LLC, TFS HealthScience, QPS Holdings LLC, ProTrial Research Inc., Lexitas Pharma Services Inc., Covance Inc., Cliantha Research Limited, Trial Runners, Iris Pharma, WuXi AppTec Co. Ltd., ORA Inc., Novotech Health Holdings Pty Limited.

North America was the largest region in the ophthalmology contract research organization market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in ophthalmology contract research organization report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ophthalmology contract research organization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ophthalmology contract research organization market includes revenues earned by entities by providing services such as preclinical research, clinical trial management, regulatory affairs, data management and biostatistics, medical imaging and reading, post-marketing surveillance, and strategic consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ophthalmology Contract Research Organization Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ophthalmology contract research organization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for ophthalmology contract research organization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ophthalmology contract research organization market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Ophthalmology Contract Research Organization Market Characteristics

3. Ophthalmology Contract Research Organization Market Trends And Strategies

4. Ophthalmology Contract Research Organization Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Ophthalmology Contract Research Organization Growth Analysis And Strategic Analysis Framework

6. Ophthalmology Contract Research Organization Market Segmentation

7. Ophthalmology Contract Research Organization Market Regional And Country Analysis

8. Asia-Pacific Ophthalmology Contract Research Organization Market

9. China Ophthalmology Contract Research Organization Market

10. India Ophthalmology Contract Research Organization Market

11. Japan Ophthalmology Contract Research Organization Market

12. Australia Ophthalmology Contract Research Organization Market

13. Indonesia Ophthalmology Contract Research Organization Market

14. South Korea Ophthalmology Contract Research Organization Market

15. Western Europe Ophthalmology Contract Research Organization Market

16. UK Ophthalmology Contract Research Organization Market

17. Germany Ophthalmology Contract Research Organization Market

18. France Ophthalmology Contract Research Organization Market

19. Italy Ophthalmology Contract Research Organization Market

20. Spain Ophthalmology Contract Research Organization Market

21. Eastern Europe Ophthalmology Contract Research Organization Market

22. Russia Ophthalmology Contract Research Organization Market

23. North America Ophthalmology Contract Research Organization Market

24. USA Ophthalmology Contract Research Organization Market

25. Canada Ophthalmology Contract Research Organization Market

26. South America Ophthalmology Contract Research Organization Market

27. Brazil Ophthalmology Contract Research Organization Market

28. Middle East Ophthalmology Contract Research Organization Market

29. Africa Ophthalmology Contract Research Organization Market

30. Ophthalmology Contract Research Organization Market Competitive Landscape And Company Profiles

31. Ophthalmology Contract Research Organization Market Other Major And Innovative Companies

32. Global Ophthalmology Contract Research Organization Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ophthalmology Contract Research Organization Market

34. Recent Developments In The Ophthalmology Contract Research Organization Market

35. Ophthalmology Contract Research Organization Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기